York Michael 4
4 · PhaseBio Pharmaceuticals Inc · Filed May 24, 2021
Insider Transaction Report
Form 4
York Michael
VP, Corporate Development
Transactions
- Award
Common Stock
2021-05-20$2.80/sh+2,897$8,112→ 7,059 total
Footnotes (1)
- [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).